Epigenetic regulation of normal and malignant hematopoiesis
- PMID: 17934479
- DOI: 10.1038/sj.onc.1210755
Epigenetic regulation of normal and malignant hematopoiesis
Abstract
The molecular processes governing hematopoiesis involve the interplay between lineage-specific transcription factors and a series of epigenetic tags, including DNA methylation and covalent histone tail modifications, such as acetylation, methylation, phosphorylation, SUMOylation and ubiquitylation. These post-translational modifications, which collectively constitute the 'histone code', are capable of affecting chromatin structure and gene transcription and are catalysed by opposing families of enzymes, allowing the developmental potential of hematopoietic stem cells to be dynamically regulated. The essential role of these enzymes in regulating normal blood development is highlighted by the finding that members from all families of chromatin regulators are targets for dysregulation in many hematological malignancies, and that patterns of histone modification are globally affected in cancer as well as the regulatory regions of specific oncogenes and tumor suppressors. The discovery that these epigenetic marks can be reversed by compounds targeting aberrant transcription factor/co-activator/co-repressor interactions and histone-modifying activities, provides the basis for an exciting field in which the epigenome of cancer cells may be manipulated with potential therapeutic benefits.
Similar articles
-
Lysine-specific histone demethylases in normal and malignant hematopoiesis.Exp Hematol. 2016 Sep;44(9):778-782. doi: 10.1016/j.exphem.2016.05.006. Epub 2016 May 18. Exp Hematol. 2016. PMID: 27208808 Free PMC article. Review.
-
Hematopoietic stem cell development: an epigenetic journey.Curr Top Dev Biol. 2014;107:39-75. doi: 10.1016/B978-0-12-416022-4.00002-0. Curr Top Dev Biol. 2014. PMID: 24439802 Review.
-
Normal and malignant hematopoiesis.Oncogene. 2007 Oct 15;26(47):6686. doi: 10.1038/sj.onc.1210753. Oncogene. 2007. PMID: 17934477 No abstract available.
-
Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger.Nature. 2009 Jun 11;459(7248):847-51. doi: 10.1038/nature08036. Nature. 2009. PMID: 19430464 Free PMC article.
-
Impact of DNA methylation programming on normal and pre-leukemic hematopoiesis.Semin Cancer Biol. 2018 Aug;51:89-100. doi: 10.1016/j.semcancer.2017.09.008. Epub 2017 Sep 28. Semin Cancer Biol. 2018. PMID: 28964938 Review.
Cited by
-
Early mammalian erythropoiesis requires the Dot1L methyltransferase.Blood. 2010 Nov 25;116(22):4483-91. doi: 10.1182/blood-2010-03-276501. Epub 2010 Aug 26. Blood. 2010. PMID: 20798234 Free PMC article.
-
DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma.Genes Chromosomes Cancer. 2009 Sep;48(9):828-41. doi: 10.1002/gcc.20687. Genes Chromosomes Cancer. 2009. PMID: 19530241 Free PMC article.
-
The extracellular signal-regulated kinase 1/2 modulates the intracellular localization of DNA methyltransferase 3A to regulate erythrocytic differentiation.Am J Transl Res. 2020 Mar 15;12(3):1016-1030. eCollection 2020. Am J Transl Res. 2020. PMID: 32269731 Free PMC article.
-
Ing4-deficiency promotes a quiescent yet transcriptionally poised state in hematopoietic stem cells.iScience. 2024 Jul 15;27(8):110521. doi: 10.1016/j.isci.2024.110521. eCollection 2024 Aug 16. iScience. 2024. PMID: 39175773 Free PMC article.
-
MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development.Blood. 2015 Mar 19;125(12):1910-21. doi: 10.1182/blood-2014-08-594655. Epub 2015 Jan 20. Blood. 2015. PMID: 25605372 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources